U.S. market Closed. Opens in 1 day 12 hours 23 minutes

RAIN | Rain Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/A
Operating Expenses77.14M51.51M18.96M10.83M
Selling, General & Admin15.74M10.74M3.59M3.54M
Research & Development61.40M40.77M15.37M7.29M
Other Operating ExpensesN/A1.00K-2.02M-251.00K
Operating Income-77.14M-51.51M-18.96M-10.83M
Other Expenses / Income1.42M120.00K-2.12M-74.00K
Before Tax Income-75.72M-51.39M-21.08M-10.90M
Income Tax Expenses3.00K2.00K-1.89M-219.00K
Net Income-75.72M-51.39M-19.20M-10.68M
Interest Expenses-1.50MN/A135.00K32.00K
Basic Shares Outstanding27.99M19.41M10.66M10.66M
Diluted Shares Outstanding27.99M19.41M10.66M10.66M
EBITDA-77.14M-51.39M-20.90M-10.84M
EBITDA Margin0.00%0.00%0.00%0.00%
EBIT-77.22M-51.39M-20.95M-10.87M
EBIT Margin0.00%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙